Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Tax Provisions of -$80000.0 for Q1 2026, down 190.91% year-on-year from $88000.0 in Q1 2025, and up 87.56% on a QoQ basis from -$643000.0 in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Tax Provisions data on file, last reported at -$80000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 190.91% year-over-year to -$80000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.0 million (down 138.15% YoY), and the FY2025 full-year result was -$837000.0, down 74.74% from the prior year.
- Tax Provisions for Q1 2026 stood at -$80000.0, up from -$643000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $190000.0 in Q2 2024 and bottomed at -$14.8 million in Q4 2022.
- The 5-year median for Tax Provisions is -$45000.0 (2022), against an average of -$970235.3.
- The widest annual swing landed in 2022, when Tax Provisions sank 2062.52%; it then soared 248.89% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$14.8 million in 2022, then soared by 98.66% to -$198000.0 in 2023, then slumped by 64.14% to -$325000.0 in 2024, then sank by 97.85% to -$643000.0 in 2025, then soared by 87.56% to -$80000.0 in 2026.
- The last three Tax Provisions figures came in at -$80000.0 (Q1 2026), -$643000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -80,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80,000.00 |
| Dec 31, 2025 | -643,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | -325,000.00 |
| Sep 30, 2024 | -375,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | -198,000.00 |
| Sep 30, 2023 | -22,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | -14.77 Mn |
| Sep 30, 2022 | -28,000.00 |
| Jun 30, 2022 | -45,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Dec 31, 2021 | -683,000.00 |
| Sep 30, 2021 | -207,000.00 |
| Jun 30, 2021 | -431,000.00 |
| Mar 31, 2021 | -159,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 6,000.00 |